Research shows promising results for a weekly injectable Parkinson's treatment that maintains consistent medication levels, ...

Detecting early rising Parkinson's disease (PD) symptoms could improve treatment outcomes by enabling earlier treatment ...

Scientists have developed a long-acting injectable treatment combining levodopa and carbidopa, the two medications used to treat Parkinson’s, which could transform how the disease is treated.

Detecting early rising Parkinson's disease (PD) symptoms could improve treatment outcomes by enabling earlier treatment ...

Scientists have developed a long-acting injectable treatment combining levodopa and carbidopa, the two medications used to treat Parkinson’s, which could transform how the disease is treated.

The three main symptoms are tremor (shaking), slowness of movement and rigidity (muscle stiffness). Subtle changes in a ...

About 90,000 people are diagnosed with Parkinson's disease (PD) each year—one person every six minutes. While most people ...

Parkinson's Disease Therapeutics Market The Parkinson's therapeutics market will grow from USD 5.92 Bn in 2024 to USD 12.83 Bn by 2033 at 8 ...

A novel biodegradable gel delivers Parkinson's medications via a single weekly shot, potentially replacing current regimens of multiple pills per day. | Drug Discovery And Development ...

The three main symptoms of Parkinson’s are tremor (shaking), slowness of movement and rigidity (muscle stiffness).

UniSA's weekly injectable gel delivers levodopa and carbidopa, potentially transforming Parkinson's care for 8.5M people by simplifying treatment and reducing side effects.

Ozzy Osbourne, Black Sabbath frontman, has died at the age of 76. He had suffered from numerous health problems and was ...